Find out more about how The Lecture List works.
Coronavirus situation updateOur lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE. |
Find out what you can do to keep The Lecture List online
|
What happens to the body when Parkinson's develops and how can science help to develop current and future treatments?
Parkinsonâs disease affects 120,000 people in the UK alone. The disease attacks the individualâs nervous system and develops slowly over time to cause a range of symptoms including tremors, muscular rigidity, slowness of movement and dementia. Although there is no known cure for Parkinsonâs disease, drugs can be prescribed which can help relieve most symptoms, and other treatments can also play a major role in managing symptoms. Recently new experimental treatments, such as deep brain stimulation, have been carried out with promising results. And the promise of stem cell research could change the way Parkinsonâs disease is tackled altogether. But what happens to the body when Parkinsonâs develops and how will science help to develop current and future treatments to bring hope to patients?
This event will see opening talks given by Dr Jane Byrne (Senior Lecturer, University of Manchester) and Prof Tipu Aziz (Consultant Neurosurgeon, Radcliffe Infirmary, Oxford). The discussion will be chaired by Linda Kelly (Chief Executive, Parkinsonâs Disease Society).
Speaker(s): |
|
|
|
Date and Time: |
16 June 2004 at 7:00 pm |
Duration: | 1 hour 30 minutes |
|
|
Venue: |
The Royal Institution of Great Britain |
|
|
Tickets: |
£8 standard, £5 concs |
Available from: |
www.rigb.org |
Additional Information: |
The event is supported by Novartis, the Daily Telegraph and the Royal College of Physicians. |
Register to tell a friend about this lecture.
If you would like to comment about this lecture, please register here.
Any ad revenue is entirely reinvested into the Lecture List's operating fund